Australian companies reported mixed results in the August earnings season, with 38% of firms surpassing analyst expectations, Jefferies data shows. As of Friday, 57% of companies scheduled to release August earnings had reported, with 19% falling short of forecasts.
Companies that beat estimates did so by an average of 4%, while those that missed fell short by 5.2%. The current season’s beat rate declined from 50% in the February 2026 reporting period, reflecting a tougher operating environment.
Earnings revisions for fiscal year 2027 showed a net downward bias: 25% of FY27 EPS estimates were raised by an average of 4%, while 44% were cut by an average of 5%. Downgrades outpaced upgrades across all sectors, signaling caution among analysts.
The healthcare sector stood out with seven of nine companies beating estimates, delivering an average beat of 4%. Notable performers included ResMed, Aristocrat Leisure, Cochlear, CSL, Pro Medicus, Sonic Healthcare and Telix Pharmaceuticals.
Consumer discretionary firms faced the opposite trend, with seven of 10 companies seeing downward revisions after results, averaging a 4% cut to estimates. Affected companies included Aconex, JB Hi-Fi, Breville, The Lottery Corporation, Temple & Webster, IDP Education and Nick Scali.
August 2026 was marked as one of the most volatile reporting seasons in the past seven periods, with volatility surging in recent weeks to approach February 2026 levels. Style rotations added to the turbulence: value stocks led in July, but growth stocks briefly outperformed in early August before reversing sharply over the following two weeks. Resources stocks also outperformed industrials following an early-August rotation, reversing a month of relative underperformance.
